Northern Light Leads $16M Series A Round In China’s Biopharma Firm Kanova
November 26, 2018 — 14:47 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese biopharmaceutical firm Kanova has secured RMB115 million (US$16.55 million) series A round of financing from Chinese venture capital firm Northern Light Venture Capital (NLVC),... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals